Related references
Note: Only part of the references are listed.Electron transfer in the complex of membrane-bound human cytochrome P450 3A4 with the flavin domain of P450BM-3: The effect of oligomerization of the heme protein and intermittent modulation of the spin equilibrium
Dmitri R. Davydov et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2010)
Redox potential control by drug binding to cytochrome p450 3A4
Aditi Das et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Mechanism-based inactivation of human cytochrome P450 enzymes and the prediction of drug-drug interactions
R. Scott Obach et al.
DRUG METABOLISM AND DISPOSITION (2007)
Structural basis for ligand promiscuity in cytochrome P450 3A4
Marika Ekroos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Kinetics and thermodynamics of ligand binding by cytochrome P450 3A4
EM Isin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Mechanism-based inactivation of CYP3A by HIV protease inhibitors
CS Ernest et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05-Å resolution
JK Yano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone
PA Williams et al.
SCIENCE (2004)
Determination of the redox properties of human NADPH-cytochrome P450 reductase
AW Munro et al.
BIOCHEMISTRY (2001)
Potent mechanism-based inhibition of human CYP3A in vitro by amprenavir and ritonavir: comparison with ketoconazole
LL von Moltke et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2000)
In vitro metabolism of trazodone by CYP3A: Inhibition by ketoconazole and human immunodeficiency viral protease inhibitors
A Zalma et al.
BIOLOGICAL PSYCHIATRY (2000)
Share Paper
